Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
3.490
-0.210 (-5.68%)
May 15, 2026, 4:00 PM EDT - Market closed
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $3.95 million as of May 15, 2026. Its market cap has decreased by -90.23% in one year.
Market Cap
3.95M
Enterprise Value
-499.33K
1-Year Change
-90.23%
Ranking
Category
Stock Price
$3.49
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $3.95M, a decrease of -98.64%. That is a compound annual growth rate of -33.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 3.95M | -70.15% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiomX | 4.17M |
| CNS Pharmaceuticals | 4.02M |
| Galmed Pharmaceuticals | 3.95M |
| Alzamend Neuro | 3.88M |
| VivoSim Labs | 3.73M |
| Soligenix | 3.71M |
| 60 Degrees Pharmaceuticals | 3.67M |
| Revelation Biosciences | 3.64M |